Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (avaa uuden ikkunan)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Lähde‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Arkistoitu‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (avaa uuden ikkunan)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (avaa uuden ikkunan)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Lähde‎: Lancet 2018;391(10116):125-32.

Arkistoitu‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (avaa uuden ikkunan)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (avaa uuden ikkunan)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Lähde‎: Am J Perinatol 2013;30(5):407-13.

Arkistoitu‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (avaa uuden ikkunan)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (avaa uuden ikkunan)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Lähde‎: Am J Perinatol 2011;28(3):233-40.

Arkistoitu‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (avaa uuden ikkunan)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (avaa uuden ikkunan)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Lähde‎: Lancet 2017;389(10084):2105-16.

Arkistoitu‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (avaa uuden ikkunan)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (avaa uuden ikkunan)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Lähde‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Arkistoitu‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (avaa uuden ikkunan)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (avaa uuden ikkunan)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Lähde‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Arkistoitu‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (avaa uuden ikkunan)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (avaa uuden ikkunan)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Lähde‎: Obstet Gynecol 2007;110(6):1270-8.

Arkistoitu‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (avaa uuden ikkunan)

The use of recombinant activated FVII in postpartum hemorrhage. (avaa uuden ikkunan)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Lähde‎: Clin Obstet Gynecol 2010;53(1):219-27.

Arkistoitu‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (avaa uuden ikkunan)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (avaa uuden ikkunan)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Lähde‎: J Perinat Med 2011;40(1):43-9.

Arkistoitu‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (avaa uuden ikkunan)

Postpartum hemorrhage: when uterotonics and sutures fail. (avaa uuden ikkunan)

James AH, McLintock C, Lockhart E.

Lähde‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Arkistoitu‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (avaa uuden ikkunan)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (avaa uuden ikkunan)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Lähde‎: Int J Hematol 2012;95(1):57-63.

Arkistoitu‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (avaa uuden ikkunan)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (avaa uuden ikkunan)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Lähde‎: J Thromb Haemost 2015;13(4):520-9.

Arkistoitu‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (avaa uuden ikkunan)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (avaa uuden ikkunan)

Lim Y, Loo CC, Chia V, Fun W.

Lähde‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Arkistoitu‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (avaa uuden ikkunan)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (avaa uuden ikkunan)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Lähde‎: Br J Haematol 2001;114(1):174-6.

Arkistoitu‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (avaa uuden ikkunan)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (avaa uuden ikkunan)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Lähde‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Arkistoitu‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (avaa uuden ikkunan)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (avaa uuden ikkunan)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Lähde‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Arkistoitu‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (avaa uuden ikkunan)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (avaa uuden ikkunan)

Pepas LP, Arif-Adib M, Kadir RA.

Lähde‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Arkistoitu‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (avaa uuden ikkunan)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (avaa uuden ikkunan)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Lähde‎: Anesth Analg 2009;109(6):1908-15.

Arkistoitu‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (avaa uuden ikkunan)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (avaa uuden ikkunan)

Prosper SC, Goudge CS, Lupo VR.

Lähde‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Arkistoitu‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (avaa uuden ikkunan)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (avaa uuden ikkunan)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Lähde‎: Transfus Med 2012;22(5):344-9.

Arkistoitu‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (avaa uuden ikkunan)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (avaa uuden ikkunan)

Bell SF, Rayment R, Collins PW, Collis RE.

Lähde‎: Int J Obstet Anesth 2010;19(2):218-23.

Arkistoitu‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (avaa uuden ikkunan)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (avaa uuden ikkunan)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Lähde‎: Br J Anaesth 2012;108(6):984-9.

Arkistoitu‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (avaa uuden ikkunan)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (avaa uuden ikkunan)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Lähde‎: J Nippon Med Sch 2014;81(2):94-6.

Arkistoitu‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (avaa uuden ikkunan)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (avaa uuden ikkunan)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Lähde‎: Haemophilia 2012;18(1):25-33.

Arkistoitu‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (avaa uuden ikkunan)

Tisseel for management of traumatic postpartum haemorrhage. (avaa uuden ikkunan)

Dhulkotia JS, Alazzam M, Galimberti A.

Lähde‎: Arch Gynecol Obstet 2009;279(3):437-9.

Arkistoitu‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (avaa uuden ikkunan)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (avaa uuden ikkunan)

Moriarty KT, Premila S, Bulmer PJ.

Lähde‎: BJOG 2008;115(6):793-5.

Arkistoitu‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (avaa uuden ikkunan)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (avaa uuden ikkunan)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Lähde‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Arkistoitu‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (avaa uuden ikkunan)

Fibrin sealant for management of complicated obstetric lacerations. (avaa uuden ikkunan)

Whiteside JL, Asif RB, Novello RJ.

Lähde‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Arkistoitu‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (avaa uuden ikkunan)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (avaa uuden ikkunan)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Lähde‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Arkistoitu‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (avaa uuden ikkunan)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (avaa uuden ikkunan)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Lähde‎: Int J Obstet Anesth 2011;20(4):293-8.

Arkistoitu‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (avaa uuden ikkunan)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (avaa uuden ikkunan)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Lähde‎: Obstet Gynecol Surv 2012;67(7):426-35.

Arkistoitu‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (avaa uuden ikkunan)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (avaa uuden ikkunan)

Karlsson O, Jeppsson A, Hellgren M.

Lähde‎: Int J Obstet Anesth 2014;23(1):10-7.

Arkistoitu‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (avaa uuden ikkunan)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (avaa uuden ikkunan)

Levy JH, Welsby I, Goodnough LT.

Lähde‎: Transfusion 2014;54(5):1389-405.

Arkistoitu‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (avaa uuden ikkunan)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (avaa uuden ikkunan)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Lähde‎: Int J Obstet Anesth 2015;24(2):174-9.

Arkistoitu‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (avaa uuden ikkunan)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (avaa uuden ikkunan)

Solomon C, Collis RE, Collins PW.

Lähde‎: Br J Anaesth 2012;109(6):851-63.

Arkistoitu‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (avaa uuden ikkunan)